▲ 0.94%
prev close
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
Congressional Trades
2
All tracked trades
Members Trading
1
Unique members
Net Activity
-2
0 buys · 2 sells
Members Who Traded This Stock
2 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2021-02-10 | TLRYTilray, Inc. - Class 2 | Sell | $50,001 - $100,000 | 1440d ago | — | |
| 2021-02-09 | TLRYTilray, Inc. - Class 2 | Sell | $15,001 - $50,000 | 1440d ago | — |
2021-02-10
Brian Mast
TLRY
Amount
$50,001 - $100,000
Filed
1440d ago
2021-02-09
Brian Mast
TLRY
Amount
$15,001 - $50,000
Filed
1440d ago
Recent News
Powered by Polygon.io
BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland
President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray
Breckenridge Distillery Launches Breck Vodka Seltzer, a Crisp New Ready-to-Drink Line Born in the Rockies
Should You Buy Tilray Stock Before July 15?
Is Tilray a Textbook Value Trap -- or the Most Undervalued Cannabis Stock on the Market?
Trade Timeline
Congressional activity, newest first
Brian Mast
2021-02-10 · Sale
$50,001 - $100,000
Brian Mast
2021-02-09 · Sale
$15,001 - $50,000